Charles Lynde, MD, FRCPC

Lynderm Research Inc.
25 Main Street Markham North
Markham, Ontario, Canada
L3P 1X2
905-471-8011


Specialty: Dermatology

Dr. Charles Lynde, Dermatologist

Research Interests: psoriasis, rosacea, onychomycosis, acne and atopic dermatitis, among other dermatological conditions.

Dr. Charles Lynde is an Associate Professor in the Department of Medicine at the University of Toronto and holds a clinical teaching position at the University Health Network. He is the Medical Director of Lynde Institute for Dermatology and Lynderm Research.  The Lynde Institute for Dermatology is a full service, comprehensive dermatology clinic.  After receiving his B.Sc. and MD, degrees at the University of Toronto, Dr. Lynde studied Dermatology at the University of British Columbia and the University of Toronto, receiving his Board Certification (Canada and USA) in 1983.

 

Lynderm Research is under the guidance of Dr. Lynde as principal investigator for more than 25 years and is actively involved in the management of psoriasis, rosacea, onychomycosis, acne and atopic dermatitis among other dermatological conditions.

 

Dr. Lynde is a member of the following professional organizations as well as having authored and co-authored more than 200 peer reviewed articles.

  • Ontario Medical Association (OMA)
  • Canadian Dermatology Association (CDA)
  • Canadian Society of Dermatologic Surgery
  • Canadian Psoriasis Foundation
  • Eczema Society of Canada
  • Toronto Dermatology Association (TDS)
  • American Academy of Dermatology (AAD)
  • American Acne & Rosacea Society
  • European Academy of Dermatology and Venereology (EADV)
  • GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis)
  • International Psoriasis Council (IPC)

Dr. Lynde has served in various roles for the CDA and AAD, including President of the Canadian Dermatology Association. He is the Editor of the CDA Bulletin and sits on the editorial boards of several journals and provides extensive consulting as well as being on the advisory boards of many pharmaceutical companies. Dr. Lynde is a frequent guest speaker both nationally and internationally at various dermatological conferences. Recognizing the need for external education he is committed to the training of new and current healthcare professionals in his community and residents through the university program.

Dr. Lynde was recently the recipient of the CSPA Dermatologist of the Year Award in 2014 and has also been the recipient the CDA Award of Merit.  Both awards represent the leadership, contributions and commitments Dr. Lynde has made to Dermatology.

 

Click to view Dr. Charles Lynde's Publications

Maurer M, Abuzakouk M, Bérard F, Canonica W, Oude Elberink H, Giménez-Arnau A, Grattan C, Hollis K, Knulst A, Lacour JP, Lynde C, Marsland A, McBride D, Nakonechna A, Ortiz de Frutos J, Proctor C, Sussman G, Sweeney C, Tian H, Weller K, Wolin D, Balp MM. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy 2017 Dec; 72(12): 2005-16. Epub 2017 Jul 10. PMID: 28543019 / doi: 10.1111/all.13209

Schöfer H, Tatti S, Lynde CW, Skerlev M, Hercogová J, Rotaru M, Ballesteros J, Calzavara-Pinton P. Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults. Int J STD AIDS 2017 Dec; 28(14): 1433-43. Epub 2017 May 31. PMID: 28566057 / doi: 10.1177/0956462417711622

Guenther LC, Kunynetz R, Lynde CW, Sibbald RG, Toole J, Vender R, Zip C. Acitretin Use in Dermatology. J Cutan Med Surg 2017 Nov/Dec; 21(3_suppl): 2S-12S. Epub 2017 Sep 27. PMID: 28952335 / doi: 10.1177/1203475417733414

Alavi A, Lynde C, Alhusayen R, Bourcier M, Delorme I, George R, Gooderham M, Gulliver W, Kalia S, Marcoux D, Poulin Y. Approach to the management of patients with hidradenitis suppurativa: a consensus document. J Cutan Med Surg 2017 Nov/Dec; 21(6): 513-24. Epub 2017 Jun 22. PMID: 28639459 / doi: 10.1177/1203475417716117

Bissonnette R, Haydey R, Rosoph LA, Lynde CW, Bukhalo M, Fowler JF, Delorme I, Gagné-Henley A, Gooderham M, Poulin Y, Barber K, Jenkin P, Landells I, Pariser DM. Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study. J Eur Acad Dermatol Venereol 2017 Oct 21 [Epub ahead of print]. PMID: 29055155 / doi: 10.1111/jdv.14647

Bissonnette R, Tamaz R, Bolduc C, Maari C, Robillard C, Nigen S, Delorme I, Lynde C. Use of capsule endoscopy to identify lesions suggestive of Crohn's disease in patients with moderate to severe psoriasis. J Am Acad Dermatol 2017 Oct; 77(4): 755-6. PMID: 28917455 / doi: 10.1016/j.jaad.2017.02.051

Lynde CW, Bourcier M, Gooderham M, Guenther L, Hong CH, Papp KA, Poulin Y, Sussman G, Vender R. A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults. J Cutan Med Surg 2017 Oct 1: 1203475417733460 [Epub ahead of print]. PMID: 29082775 / doi: 10.1177/1203475417733460

Bissonnette R, Harel F, Krueger JG, Guertin MC, Chabot-Blanchet M, Gonzalez J, Maari C, Delorme I, Lynde CW, Tardif JC. J Invest Dermatol 2017 Oct; 137(10): 2237-8. Epub 2017 Jun 23. PMID: 28652110 / doi: 10.1016/j.jid.2017.05.027

Mehdizadeh A, Alavi A, Alhusayen R, Bauer B, Bechara FG, Bourcier M, Brassard A, Djamei V, Dutz J, George R, Ghias M, Gooderham M, Hamzavi I, Hoffman LK, Hou A, Hu H, Kimball AB, Kirchhof M, Kryzskaya D, Liy Wong MDC, Lowes MA, Lynde CW, McLellen C, Prens E, Prens L, Rogalska T, Sibbald RG, Sisic M, Tan MG, Wong DD. Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA). Exp Dermatol 2017 Sep 12 [Epub ahead of print]. PMID: 28898476 / doi: 10.1111/exd.13445

Bissonnette R, Bourcier M, Gooderham M, Hong CH, Landells I, Lynde C, Papp K, Poulin Y, Vender R, Wiseman MC. Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition. J Cutan Med Surg 2017 Sep/Oct; 21(2_suppl): 2S-40S. PMID: 29156950 / doi: 10.1177/1203475417722552

Gold LS, Papp K, Lynde C, Lain E, Gooderham M, Johnson S, Kerrouche N. Treatment of rosacea with concomitant use of topical ivermectin 1% cream and brimonidine 0.33% gel: A randomized, vehicle-controlled study. J Drugs Dermatol 2017 Sep 1; 16(9): 909-16. PMID: 28915286

Fleming P, Zhou S, Bobotsis R, Lynde C. Comparison of the treatment guidelines for actinic keratosis: a critical appraisal and review. J Cutan Med Surg 2017 Sep/Oct; 21(5): 408-17. Epub 2017 May 16. PMID: 28510496 / doi: 10.1177/1203475417708166

Lima H, Gooderham M, Dutz J, Lynde C, Chapdelaine H, Ellis A, Gilbert M, Ho V, Papp K, Poulin Y, Sussman G. Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome. Allergy Asthma Clin Immunol 2017 Aug 24; 13: 38. eCollection 2017. PMID: 28852410 / doi: 10.1186/s13223-017-0210-0

Bissonnette R, Harel F, Krueger JG, Guertin MC, Chabot-Blanchet M, Gonzalez J, Maari C, Delorme I, Lynde CW, Tardif JC. TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study. J Invest Dermatol 2017 Aug; 137(8): 1638-45. Epub 2017 Mar 9. PMID: 28286061 / doi: 10.1016/j.jid.2017.02.977

Iversen L, Lange MM, Bissonette R, Carvalho AV, van de Kerkhof PC, Kirby B, Kleyn CE, Lynde CW, van der Walt JM, Wu JJ. Topical treatment of psoriasis: questionnaire results on topical therapy accessibility and influence of body surface area on usage. J Eur Acad Dermatol Venereol 2017 Jul; 31(7): 1188-95. Epub 2017 Apr 19. PMID: 28370534 / doi: 10.1111/jdv.14250

Papp K, Albrecht L, Barber K, Bourcier M, Dion P-L, Freiman A, Gooderham M, Guenther L, Gulliver W, Hong C, Lynde C, Poulin Y, Siddha S, Toole J, Toth D, Vender R, Wasel N, Wiseman M. An open letter to Health Canada. J Cutan Med Surg 2017; 21(3): 195-6. doi: 10.1177/1203475417704642

Fleming P, Bai JW, Pratt M, Sibbald C, Lynde C, Gulliver WP. The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials. J Eur Acad Dermatol Venereol 2017 May; 31(5): 798-807. Epub 2016 Sep 12. PMID: 27620704 / doi: 10.1111/jdv.13891

Gladman DD, Poulin Y, Adams K, Bourcier M, Barac S, Barber K, Chandran V, Dutz J, Flanagan C, Gooderham MJ, Gulliver WP, Ho VC, Hong C, Karsh J, Khraishi MM, Lynde CW, Papp KA, Rahman P, Rohekar S, Rosen CF, Russell AS, Vender RB, Yeung J, Ziouzina O, Zummer M. Treating psoriasis and psoriatic arthritis: position paper on applying the treat-to-target concept to Canadian daily practice. J Rheumatol 2017; 44(4): 519-34.

Gupta AK, Cernea M, Lynde CW. Tofacitinib in the treatment of rheumatoid arthritis and chronic plaque psoriasis. Skin Therapy Lett 2017 Mar; 22(2): 1-7. PMID: 28329404

Gooderham M, Lynde CW, Papp K, Bourcier M, Guenther L, Gulliver W, Hong CH, Poulin Y, Sussman G, Vender R. Review of systemic treatment options for adult atopic dermatitis. J Cutan Med Surg 2017 Jan/Feb; 21(1): 31-9. Epub 2016 Sep 22. PMID: 27635033 / doi: 10.1177/1203475416670364

Guenther LC, Andriessen A, Lynde CW, Toole JW, Sibbald RG, Bergman JN, Bourcier M, Landells ID. Development of a clinical pathway for atopic dermatitis patients: A case-based approach. J Drugs Dermatol 2016 Dec 1; 15(12): 1485-94. PMID: 28095572

Gooderham M, Bourcier M, de Gannes G, Dhadwal G, Fahim S, Gulliver W, Landells I, Lynde C, Metelitsa A, Nigen S, Poulin Y, Pratt M, Shear NH, Siddha S, Taher Z, Vender R. Management of Chronic Hand Dermatitis: A Practical Guideline for the General Practitioner. Skin Therapy Letter - Family Practice Edition 2016; 11(1)

Alavi A, Adam DN, Alhusayan R, Boucier M, Brassard A, Coutts P, Gooderham M, Gulliver W, Hong CH, Lynde C, Marcoux D, Papp K, Poulin Y, Sibbald RG, Shear NH. Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF). J Cutan Med Surg 2016 Nov; 20(6): 613-15. PMID: 27821541

Bobotsis R, Gulliver WP, Monaghan K, Lynde C, Fleming P. Psoriasis and adverse pregnancy outcomes: A systematic review of observational studies. Br J Dermatol 2016 Sep; 175(3): 464-72. Epub 2016 Jul 24. PMID: 26991866 / doi: 10.1111/bjd.14547

Asai Y, Tan J, Baibergenova A, Barankin B, Cochrane CL, Humphrey S, Lynde CW, Marcoux D, Poulin Y, Rivers JK, Sapijaszko M, Sibbald RG, Toole J, Ulmer M, Zip C. Canadian clinical practice guidelines for rosacea. J Cutan Med Surg 2016 Sep; 20(5): 432-45. Epub 2016 May 17. PMID: 27207355 / doi: 10.1177/1203475416650427

Gupta AK, Gupta G, Jain HC, Lynde CW, Foley K, Daigle D, Cooper EA, Summerbell RC. The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians' offices. J Eur Acad Dermatol Venereol 2016 Sep; 30(9): 1567-72. Epub 2016 May 11. PMID: 27168494 / doi: 10.1111/jdv.13677

Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, Zouboulis CC, Armstrong AW, Kerdel F, Gold MH, Forman SB, Korman NJ, Giamarellos-Bourboulis EJ, Crowley JJ, Lynde C, Reguiai Z, Prens EP, Alwawi E, Mostafa NM, Pinsky B, Sundaram M, Gu Y, Carlson DM, Jemec GB. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. N Engl J Med 2016 Aug 4; 375(5): 422-34. PMID: 27518661 / doi: 10.1056/NEJMoa1504370

Cheung LY, Lynde CW. Chronic spontaneous urticaria (CSU): Canadian dermatologists’ perspective. J Cutan Med Surg 2016 Jul; 20(4): 308-12. Epub 2016 Feb 1. PMID: 26834118 / doi: 10.1177/1203475416631521

Wu JJ, Lynde CW, Kleyn CE, Iversen L, van der Walt JM, Carvalho A, Kirby B, Bissonnette R. Identification of key research needs for topical therapy treatment of psoriasis - a consensus paper by the International Psoriasis Council. J Eur Acad Dermatol Venereol 2016 Jul; 30(7): 1115-9. Epub 2016 Mar 10. PMID: 26969587 / doi: 10.1111/jdv.13614

Armstrong AW, Lynde CW, McBride SR, Ståhle M, Edson-Heredia E, Zhu B, Amato D, Nikaï E, Yang FE, Gordon KB. Effect of ixekizumab treatment on work productivity for patients with moderate-to-severe plaque psoriasis: Analysis of results from 3 randomized phase 3 clinical trials. JAMA Dermatol 2016 Jun 1; 152(6): 661-9. PMID: 26953848 / doi: 10.1001/jamadermatol.2016.0269

Richer V, Roubille C, Fleming P, Starnino T, McCourt C, McFarlane A, Siu S, Kraft J, Lynde C, Pope JE, Keeling S, Dutz J, Bessette L, Gulliver WP, Haraoui B, Bissonnette R. Psoriasis and smoking: a systematic literature review and meta-analysis with qualitative analysis of effect of smoking on psoriasis severity. J Cutan Med Surg 2016 May; 20(3): 221-7. Epub 2015 Nov 9. PMID: 26553732 / doi: 10.1177/1203475415616073

Asai Y, Baibergenova A, Dutil M, Humphrey S, Hull P, Lynde C, Poulin Y, Shear NH, Tan J, Toole J, Zip C. Management of acne: Canadian clinical practice guideline. CMAJ 2016 Feb 2; 188(2):118-26. Epub 2015 Nov 16. PMID: 26573753 / doi: 10.1503/cmaj.140665

Moolani Y, Lynde C, Sussman G. Advances in understanding and managing chronic urticaria. F1000Res 2016 Feb 16; 5. PMID: 26949520 / doi: 10.12688/f1000research.7246.1

Lynde CW, Andriessen A, Bertucci V, McCuaig C, Skotnicki S, Weinstein M, Wiseman M, Zip C. The skin microbiome in atopic dermatitis and its relationship to emollients. J Cutan Med Surg 2016 Jan; 20(1):21-8. Epub 2015 Oct 22. PMID: 26492918 / doi: 10.1177/1203475415605498

Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B. Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: expert opinion of the Canadian dermatology-rheumatology comorbidity initiative. J Rheumatol 2015 Oct; 42(10):1767-80. Epub 2015 Jul 15. PMID: 26178281 / doi: 10.3899/jrheum.141112

Fleming P, Kraft J, Gulliver WP, Lynde C. The relationship of obesity with the severity of psoriasis: A systematic review. J Cutan Med Surg 2015 Sep-Oct; 19(5):450-6. Epub 2015 May 7. PMID: 26271963 / doi: 10.1177/1203475415586332

Tan J, Frey MP, Knezevic S, Poulin Y, Lynde CW, Gulliver WP, Gupta AK, Sebaldt RJ, Thomas DR, Sapra S. The relationship between dermatologist- and patient-reported acne severity measures and treatment recommendations. J Cutan Med Surg 2015 Sep-Oct; 19(5):464-9. Epub 2015 Mar 11. PMID: 25775621 / doi: 10.1177/1203475415576464

Sapra P, Rosen C, Siddha S, Lynde CW. Dysplastic nevus: management by Canadian dermatologists. J Cutan Med Surg 2015 Sep-Oct; 19(5):457-63. Epub 2015 Apr 1. PMID: 25834273 / doi: 10.1177/1203475415575234

Papp KA, Barber K, Bissonnette R, Bourcier M, Lynde CW, Poulin Y, Shelton J, Garces K, Toole J, Poulin-Costello M. Improvements in patient-reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE. J Eur Acad Dermatol Venereol 2015 Aug; 29(8):1555-61. Epub 2015 Jan 21. PMID: 25611084 / doi: 10.1111/jdv.12934

Bissonnette R, Maari C, Barber K, Lynde CW, Vender R. Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab. J Eur Acad Dermatol Venereol 2015 Aug; 29(8):1576-81. Epub 2015 Jan 20. PMID: 25600828 / doi: 10.1111/jdv.12943

Guenther LC, Barber K, Searles GE, Lynde CW, Janiszewski P, Ashkenas J; Canadian Non-melanoma Skin Cancer Guidelines Committee. Non-melanoma skin cancer in Canada chapter 1: introduction to the guidelines. J Cutan Med Surg 2015 May; 19(3):205-15. Epub 2015 May 27. PMID: 26016676 / doi: 10.1177/1203475415588652

Poulin Y, Lynde CW, Barber K, Vender R, Claveau J, Bourcier M, Ashkenas J; Canadian non-Melanoma Skin Cancer Guidelines Committee. Non-melanoma skin cancer in Canada chapter 3: management of actinic keratoses. J Cutan Med Surg 2015 May; 19(3):227-38. Epub 2015 Apr 29. PMID: 25926621 / doi: 10.1177/1203475415583414

Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B. Response to: 'drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr Boers. Ann Rheum Dis 2015 May; 74(5):e34. Epub 2015 Mar 9. PMID: 25755140 / doi: 10.1136/annrheumdis-2015-207419

Siu S, Haraoui B, Bissonnette R, Bessette L, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Kraft J, Lynde C, Gulliver W, Keeling S, Dutz J, Pope JE. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials. Arthritis Care Res (Hoboken) 2015 May; 67(6):754-64. PMID: 25418272 / doi: 10.1002/acr.22519

Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B. The effects of tumor necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2015 Mar; 74(3): 480-489. Epub 2015 Jan 5. PMID: 25561362 / doi: 10.1136/annrheumdis-2014.206624

Sussaman G, Hérbert J, Gulliver W, Lynde C, Waserman C, Kanani A, Ben-Shoshan M, Horemans S, Barron C, Betschel S, Yang WH, Dutz J, Shear N, Lacuesta G, Vadas P, Kobayashi K, Lima H, Simons FE. Insights and chronic urticarial: a Canadian perspective. Allergy Asthma Clin Immunol 2015 Feb; 11(1):7. Epub 2015 Feb 11. PMID: 25705232 / doi: 10.1186/s13223-015-0072-2

Papp KA, Barber K, Bissonnette R, Bourcier M, Lynde CW, Poulin Y, Shelton J, Toole J, Vieria A, Poulin-Costello M. A randomized, blinded assessor study to evaluate the efficacy and safety of etanercept 50 mg once weekly plus as needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE). J Eur Acad Dermatol Venereol 2015 Feb; 29(2): 361-6. Epub 2014 Jul 1. PMID: 24980988 / doi: 10.1111/jdv.125555

Gulliver W, Lynde C, Dutz JP, Vender RB, Yeung J, Bourcier M, Dion PL, Hong CH, Searles G, Poulin Y. Think beyond the skin: 2014 Canadian expert opinion paper on treating to target in plaque psoriasis. J Cutan Med Surg 2015 Jan-Feb; 19(1):22-7. Epub 2015 Jan 1. PMID: 25775659 / doi: 10.2310/7750.2014.13151

Fleming P, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Siu S, Kraft K, Lynde C, Pope JE, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B, Gulliver WP. Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review. J Eur Acad Dermatol Venereol 2015 Jun; 29(6):1063-70. Epub 2014 Dec 10. PMID: 25490866 / doi: 10.1111/jdv.12909

Tan J, Humphrey S, Vender R, Barankin B, Gooderham M, Kerrouche N, Audibert N, Lynde C; POWER study group. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin. Br J Dermatol 2014 Dec; 171(6): 1508-16. Epub 2014 Oct 28. PMID: 24934963 / doi: 10.1111/bjd.13191

Stein Gold L, Kircik L, Fowler J, Jackson JM, Tan J, Draelos Z, Fleischer A, Appell M, Steinhoff M, Lynde C, Sugarman J, Liu H, Jacovella J. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trial. J Drugs Dermatol 2014 Nov; 13(11): 1380-6. PMID: 25607706

Andriessen A, Lynde CW. Antibiotic resistance: shifting the paradigm in topical acne treatment. J Drugs Dermatol 2014 Nov 1; 13(11): 1358-64. PMID: 25607703

Bissonnette R, Nigen S, Langley RG, Lynde CW, Tan J, Fuentes-Duculan J, Krueger JG. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial. J Eur Acad Dermatol Venereol 2014 Oct; 28(10): 1298-305. Epub 2013 Sep 24. PMID: 24112799 / doi: 10.1111/jdv.12272

Lynde C, Tan J, Andriessen A, Barankin B, Dutil M, Gilbert M, Hong CH, Humphrey S, Rochette L, Toole J, Thomas R, Vender R, Wiseman M, Zip C. A consensus on acne management focused on specific patients features. J Cutan Med Surg 2014 Jul-Aug; 18(4): 243-55. PMID: 25008441

Lynde CW, Poulin Y, Vender R, Bourcier M, Khalil S. Interleukin 17A: toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol 2014 Jul; 71(1): 141-50. Epub 2014 Mar 18. PMID: 24655820 / doi: 10.1016/j.jaad.2013.12.036

Lynde CW, Andriessen A. A cohort study on a ceramide-containing cleanser and moisturizer used for atopic dermatitis. Cutis 2014 Apr; 93(4): 207-13. PMID: 24818182

Lynde CW, Andriessen A, Barankin B, Gannes GD, Gulliver W, Haber R, McCuaig C, Rajan P, Skotnicki SP, Thomas R, Toole J, Vender R. Moisturizers and ceramide-containing moisturizers may offer concomitant therapy with benefits. J Clin Aesthet Dermatol 2014 Mar; 7(3): 18-26. PMID: 24688622

Lynde C, Gunton L, Weinberg T, Murray C. Periorbital surface anatomy for the dermatologist. J Cutan Med Surg 2014 Mar-Apr; 18(2): 141-4. PMID: 24636442

Stein L, Kircik L, Fowler J, Tan J, Draelos Z, Fleischer A, Appell M, Steinhoff M, Lynde C, Liu H, Jacovella J. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. J Drugs Dermatol 2014 Mar; 13(3): 316-23. PMID: 24595578

Lynde CW, Andriessen A. Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women. Skinmed 2014 Jan-Feb; 12(1): 15-21. PMID: 24720080

McFarlane A, Roubille C, Richer V, Starnino T, McCourt C, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Dutz J, Bessette L, Bissonnette R, Haraoui B, Keeling SO. Cardiovascular outcomes in patients with rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analyses. Ann Rheum Dis 2014; 73 Suppl 2: 324-325. doi: 10.1136/annrheumdis-2014-eular.1348

Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B. Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic literature search and expert opinion. Ann Rheum Dis 2014; 73 Suppl 2: 635. doi: 10.1136/annrheumdis-2014-eular.2274

Bourcier M, Bhatia N, Lynde C, Vender R. Managing external genital warts: practical aspects of treatment and prevention. J Cutan Med Surg 2013 Dec; 17 Suppl 2:S68-75. PMID: 24388561

Vender R, Bourcier M, Bhatia N, Lynde C. Therapeutic options for external genital warts. J Cutan Med Surg 2013 Dec; 17 Suppl 2:S61-7. PMID: 24388560

Lynde C, Vender R, Bourcier M, Bhatia N. Clinical features of external genital warts. J Cutan Med Surg 2013 Dec; 17 Suppl 2:S55-60. PMID: 24388559

Bhatia N, Lynde C, Vender R, Bourcier M. Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus. J Cutan Med Surg 2013 Dec; 17 Suppl 2:S47-54. PMID: 24388558

Papp K, Guenther L, Shear N, Binder C, Tan J, Lynde C, Gulliver W, Stang P. Understanding and assessing potential serious adverse events: a practical approach to understanding the benefits and harm of psoriasis treatments. J Cutan Med Surg 2013 May-Jun; 17(3): 189-96. PMID: 23673302

Vender R, Lynde C, Gilbert M, Ho V, Sapra S, Poulin-Costello M. One-year, multi-center, open-label, single-arm study evaluating the safety and effectiveness of etanercept for the treatment of moderate-to-severe plaque psoriasis in a Canadian population. J Cutan Med Surg 2013 Mar-Apr; 17(2): 129-38. PMID: 23582167

Tyring S, Bagel J, Lynde C, Klekotka P, Thompson EH, Gandra SR, Shi Y, Kricorian G. Patient-reported outcomes in moderate-to-severe plaque psoriasis with scalp involvement: results from a randomized, double-blind, placebo-controlled study of etanercept. J Eur Acad Dermatol Venereol 2013 Jan; 27(1): 125-8. Epub 2011 Dec 21. PMID: 22188302 / doi: 10.1111/j.1468-3083.2011.04394.x

Levy AR, Davie AM, Brazier NC, Jivraj F, Albrecht LE, Gratton D, Lynde CW. Economic burden of moderate to severe plaque psoriasis in Canada. Int J Dermatol 2012 Dec; 51(12): 1432-40. PMID: 23171010 / doi: 10.1111/j.1365-4632.2011.05359.x

Vender R, Lynde C, Gilbert M, Ho V, Sapra S, Poulin-Costello M. Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practice. J Cutan Med Surg 2012 Nov-Dec; 16(6): 407-16. PMID: 23149196

Papp K, Poulin Y, Barber K, Lynde C, Prinz JC, Berg M, Kerrouche N, Rives VP. Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European anaylsis. J Eur Acad Dermatol Venereol 2012 Nov; 26(11): 1407-14. Epub 2011 Oct 27. PMID: 22032474 / doi: 10.1111/j.1468-3083.2011.04305.x

Lynde C, Cambazard F, Ruzicka T, Sebastian M, Brown TC, Maares J. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment. Clin Exp Dermatol 2012 Oct; 37(7): 712-7. Epub 2012 Jun 25. PMID: 22731739 / doi: 10.1111/j.1365-2230.2012.04396.x

Vender R, Lynde C, Ho V, Chau D, Poulin-Costello M. Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multi-centre, open-label, single-arm study in a clinical setting. Appl Health Econ Health Policy 2012 Sep 1; 10(5): 343-53. PMID: 22877226 / doi: 10.2165/11633980-000000000-00000

Lynde CW, Gupta AK, Guenther L, Poulin Y, Levesque A, Bissonnettte R. A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept. J Dermatolog Treat 2012 Aug; 23(4): 261-7. Epub 2011 Aug 10. PMID: 21797805 / doi: 10.3109/09546634.2011.607795

Papp K, Ho V, Teixeira HD, Guerette B, Chen K, Lynde C. Efficacy and safety of adalimumab when added to inadequate therapy for the treatment of psoriasis: results of PRIDE, an open-label, multi-centre, phase IIIb study. J Eur Acad Dermatol Venereol 2012 Aug; 26(8): 1007-13. Epub 2011 Oct 25. PMID: 22023702 / doi: 10.1111/j.1468-3083.2011.04225.x

Bagel J, Lynde C, Tyring S, Kricorian G, Shi Y, Klekotka P. Moderate to severe plaque psoriasis with scalp involvement: a randomized, double-blind, placebo-controlled study of etanercept. J Am Acad Dermatol 2012 Jul; 67(1): 86-92. Epub 2011 Oct 20. PMID: 22014541 / doi: 10.1016/j.jaad.2011.07.034

Thomas R, Landells I, Lynde C, Withers M, Weinstein M, Kunynetz R, Haber R, Balbul A, Dion PL. Canadian consensus on skin barrier repair therapy in atopic dermatitis. J Cutan Med Surg 2012 Mar-Apr; 16 Suppl 1:S1-15. PMID: 23577504 / doi: 10.2310/7750.2012.S1PEDIA

Guenther L, Lynde CW, Andriessen A, Barankin B, Goldstein E, Skotnicki SP, Gupta SN, Choi KL, Rosen N, Shapiro L, Sloan K. Pathway to dry skin prevention and treatment. J Cutan Med Surg 2012 Jan-Feb; 16(1): 23-31. PMID: 22417992

Bissonnette R. Poulin Y, Guenther L, Lynde CW, Bolduc C, Nigen S. Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study. J Eur Acad Dermatol Venereol 2011 Dec; 25(12): 1402-8. Epub 2011 Feb 23. PMID: 21349113 / doi: 10.1111/j.1468-3083.2011.03984.x

Lynde C, Krell J, Korman N, Mathes B, Vaccine Study Investigators. Immune response to pneumococcal polysaccharide vaccine in adults with chronic plaque psoriasis treated with alefacept. J Am Acad Dermatol 2011 Oct; 65(4): 799-506. Epub 2011 Mar 30. PMID: 21453987 / doi: 10.1016/j.jaad.2010.04.040

Papp K, Gulliver W, Lynde C, Poulin Y, Ashkenas J, for the Canadian Psoriasis Guidelines Committee. Canadian guidelines for the management of plaque psoriasis: overview. J Cutan Med Surg 2011 Jul-Aug; 15(4):210-9. PMID: 21781627

Guenther LC, Lynde CW. A refresher on herpes zoster, current status on vaccination, and the role of the dermatologist. J Cutan Med Surg 2011 Jul-Aug; 15(4): 185-91. PMID: 21781624

Tyring S, Bagel J, Lynde CW, et al. Improvement in scalp psoriasis in patients with moderate to severe plaque psoriasis on etanercept therapy. International Literature Search in Dermatology 2011 Jul; 3(2).

Lynde CW, Kraft JN, Lynde CB. Acitretin revisited. Skin Therapy Lett 2011 Mar; 16(3): 1-4. PMID: 21611678

Lynde C, Guenther L, Diepgen TL, Sasseville D, Poulin Y, Gulliver W, Agner T, Barber K, Bissonnette R, Ho V, Shear NH, Toole J. Canadian hand dermatitis management guidelines. J Cutan Med Surg 2010 Nov-Dec; 14(6): 267-84. PMID: 21084020 / doi: 10.2310/7750.2010.09094

Eichenfield LE, Jorizzo JL, Dirschka T, Taub AF, Lynde C, Graeber M, Kerrouche N. Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety. J Drugs Dermatol 2010 Nov; 9(11): 1395-401. PMID: 21061762

Aubert J, Reiniche P, Fogel P, Poulin Y, Lui H, Lynde C, Shapiro J, Villemagne H, Soto P, Voegel JJ. Gene expression profiling in psoriatic scalp hair follicles: clobetasol propionate shampoo 0.05% normalizes psoriasis disease markers. J Eur Acad Dermatol Venereol 2010 Nov; 24(11):1304-11. PMID: 20337827 / doi: 10.1111/j.1469-3083.2010.03637.x

Bissonnette R, Bolduc C, Poulin Y, Guenther L, Lynde CW, Maari C. Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept. J Am Acad Dermatol 2010 Aug; 63(2): 228-34. Epub 2010 May 21. PMID: 20494479 / doi: 10.1016/j.jaad.2009.08.040

Tan JK, Tang J, Fung K, Gupta AK, Richard Thomas D, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Development and validation of a scale for acne scar severity (SCAR-S) of the face and trunk. J Cutan Med Surg 2010 Jul-Aug; 14(4): 156-60. PMID: 20642983

Bissonnette R, Diepgen TL, Elsner P, English J, Graham-Brown R, Homey B, Luger T, Lynde C, Maares J, Maibach HI. Redefining treatment options in chronic hand eczema (CHE). J Eur Acad Dermatol Venereol 2010 May; 24 (s3):1-20. PMID: 20443999 / doi: 10.1111/j.1468-3083.2010.03615.x

Lynde C, Haarsch M, Basilea Pharmaceutica International, Poulin Y. Alitretinoin is effective in clearing severe chronic hand eczema. J Am Acad Dermatol 2010 Mar; 62(3):1405-AB50.

Poulin Y, Papp K, Bissonnette R, Guenther L, Tan J, Lynde C, Kerrouche N, Villemagne H; CalePso Study Team. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis. Cutis 2010 Jan; 85(1): 43-50. PMID: 20184211

Lynde CW, Sapra S. Predictive testing of the melanocortin 1 receptor for skin cancer and photoaging. Skin Therapy Lett 2010 Jan; 15(1): 5-7. PMD: 20066389

Bissonnette R, Searles G, Landells I, Shear NH, Papp K, Lui H, Gulliver WP, Lynde C. The AWARE study: methodology and baseline characteristics. J Cutan Med Surg 2009 Dec; 13 Suppl 3:S11-21. PMID: 20053323

Lynde CW, Poulin Y, Guenther L, Jackson C. The burden of psoriasis in Canada: insights from the pSoriasis Knowledge IN Canada (SKIN) survey. J Cutan Med Surg 2009 Sep-Oct; 13(5): 235-52. PMID: 19769832

Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, Kavanaugh A, Krueger GG, Langley RG, Lynde C, McHugh N, Mease P, Oliveri I, Rahman P, Rosen CF, Salvarani C, Thaci D, Toloza SM, Wong MY, Zhou QM, Gladman DD. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthrit Rheum-Arthr 2009 Sep 15; 61(9): 1235-42. PMID: 19714610 / doi: 10.1002/art.24562

Tan JK, Balagurusamy M, Fung AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Effect of quality of life impact and clinical severity on adherence to topical acne treatment. J Cutan Med Surg 2009 Jul-Aug; 13(4): 204-8. PMID: 19706228

Chan B, Hales B, Shear N, Ho V, Lynde C, Poulin Y, Mittmann N. Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis. J Cutan Med Surg 2009 Jul-Aug; 13(4): 192-7. PMID: 19706226

Kraft JN, Lynde CB, Lynde CW. Moisturizers: An Essential Component in Eczema Management. Skin Therapy Letter 2009 Jun; 5(2):5-7.

Lynde C, Guenther L, Poulin Y. The burden of psoriasis and psoriatic arthritis in Canada: insights from the psoriasis knowledge in Canada (SKIN) survey. J Am Acad Dermatol 2009 Mar; 60(3S1):AB165. doi: http://dx.doi.org/10.1016/j.jaad.2008.11.723

Lynde C, Ohson K, Shaffelburg M, Vender R. Efalizumab’s effectiveness in treating plaque psoriasis affecting the hands/feet, scalp, and nails: interim subanalysis of the Canadian RESTORE study data. J Am Acad Dermatol 2009 Mar; 60(3S1):AB182. doi: http://dx.doi.org/10.1016/j.jaad.2008.11.789

Lynde C. Use of biologic therapeutics in difficult-to-treat psoriasis. J Cutan Med Surg 2009 Jan-Feb; 13(1): 6-17. PMID: 19298766

Gupta AK, Langley RG, Lynde C, Barber K, Gulliver W, Lauzon G, Aspeslet LJ, Foster RT, Huizinga RB, Yatscoff RW. ISA247: quality of life results from a phase II, randomized, placebo-controlled study. J Cutan Med Surg 2008 Nov-Dec; 12(6): 268-75. PMID: 19317948

Lynde C. Moisturizers for the treatment of inflammatory skin conditions. J Drugs Dermatol 2008 Nov; 7(11): 1038-43. PMID: 19110734

Tan JK, Li Y, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Divergence of demographic factors associated with clinical severity compared with quality of life impact in acne. J Cutan Med Surg 2008 Sep-Oct; 12(5): 235-42. PMID: 18845093

Kim H, Lynde C. Impact of desloratadine on symptoms and quality of life in subjects with chronic idiopathic urticarial: A multicenter, practice-based study. Arch Drug Inf 2008 Sep; 1(2): 63-69. PMID: 19915710

Tan JK, Tang J, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Prevalence and severity of facial and truncal acne in a referral cohort. J Drugs Dermatol 2008 Jun; 7(6): 551-6. PMID: 18561586

Papp K, Bissonnette R, Rosoph L, Wasel N, Lynde CW, Searles G, Shear NH, Huizinga RB, Maksymowych WP. Efficacy of ISA247 in plaque psoriasis: a randomized, multicenter, double-blind, placebo-controlled phase III study. Lancet 2008 Apr 19; 371(9621): 1337-42. PMID: 18424323 / doi: 10.1016/S0140-6736(08)60593-0

Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones, Coenraads PJ, Kaszuba A, Bissonnette R, Varjonen E, Hollo P, Cambazard F, Lahfa M, Elsner P, Nyberg F, Svensson A, Brown TC, Marsch M, Maares J. Efficacy and safety or oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008 Apr; 158(4): 808-17. Epub 2008 Feb 21. PMID: 18294310 / doi: 10.1111/j.1365-2133.2008.08487.x

Lynde C. Pimecrolimus cream 1% in the treatment of pediatric atopic dermatitis. Pediatric Health 2007 Dec; 1(2):149-159. doi: 10.2217/17455111.1.2.149

Tan JK, Tang J, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Development and validation of a comprehensive acne severity scale. J Cutan Med Surg 2007 Nov-Dec; 11(6): 211-6. PMID: 18042334

Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C, Lupin M, Smith KC, Storwick G; Canadian Hyperhidrosis Advisory Committee. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg 2007 Aug; 33(8): 908-23. PMID: 17661933 / doi: 10.1111/j.1524-4725.2007.33192.x

Lynde C. Use of Biological Therapeutics in difficult-to-treat Psoriasis. J Cutan Med Surg 2007 Jul; 11(4).

Gupta AK, Lynde CW, Poulin Y, Smith K, Lewis R, Zip C; Pharmacy and Therapeutics Committee, Canadian Dermatology Association. Position statement for isotretinoin. J Cutan Med Surg 2007 May-Jun; 11(3): 123-4. PMID: 17511927

Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C, Garrett S; United States/Canada Dapsone Gel Study Group. Two randomized studies demonstrated the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol 2007 Mar; 56(3): 439 e1-10. Epub 2007 Jan 17. PMID: 17208334 / doi: 10.1016/j.jaad.2006.10.005

Gupta AK, Poulin Y, Lynde CW. Canadian Perspectives on Antifungal Treatment for Onychomycosis. J Cutan Med Surg 2006 Dec; 10(S2).

Guenther L, Lynde CW, Zip C. Mexoryl: Broad Spectrum Ultraviolet a Photoprotection. J Cutan Med Surg 2006 Dec; 10(S2):S22-S25.

Vender R, Lynde CW, Poulin Y. Prevalance and epidemiology of onychomycosis. J Cutan Med Surg 2006 Dec; 10(S2):S28-S33.

Lynde C, Dakin P. Alefacept: clinical use in treating psoriasis. Expert Review of Dermatology 2006 Dec; 1(6):781-790. doi: 10.1586/17469872.1.6.781

Gupta AK, Gover MD, Lynde CW. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus. J Eur Acad Dermatol Venereol 2006 Nov; 20(10): 1188-93. PMID: 17062029 / doi: 10.1111/j.1468-3083.2006.01698.x

Lynde CB, Kraft JN, Lynde CW. Topical treatments for melasma and post inflammatory hyperpigmentation. Skin Therapy Letter 2006 Nov; 11(9):1-6.

Kraft JN, Lynde CB, Lynde CW. Skin neoplasias in older adults. Geriatrics & Aging 2006 May; 9(5).

Lynde C. Efalizumab: intergrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis. J Cutan Med Surg 2005 Dec; 9(S1):1-3. PMID: 16633863

Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, Toole J, Zip C. Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches. J Cutan Med Surg 2005 Dec; 9(S1): 18-25. PMID: 16633860

Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis. J Cutan Med Surg 2005 Dec; 9(S1): 26-32. PMID: 16633859

Lynde CW. All That Scales is not Flaky – Is It Psoriasis? Skin Therapy Letter 2005 Nov; 10(9).

Kraft JN, Lynde CB, Lynde CW, Mahler R. Recalcitrant necrobiotic xanthogranuloma responding to multiple infusions of infliximab. J Cutan Med Surg 2005 Oct; 9(5).

Kraft J, Lynde C. Moisturizers: what they are and a practical approach to product selection. Skin Therapy Letter 2005 Jun; 10(5):1-8. PMID: 15986082

Eichenfield LF, Lucky AW, Langley RG, Lynde C, Kaufmann R, Todd G, Lindsley L, Barbier N, Felser JM. Use of pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome. Int J Dermatol 2005 Jan; 44(1): 70-5. PMID: 15663667

Lynde C, Barber K, Claveau J, Gratton D, Ho V, Krafchik B, Langley R, Marcoux D, Murray E, Shear N. Canadian practical guide for the treatment and management of atopic dermatitis. J Cutan Med Surg 2005; 8(S5): 1-9. PMID: 19830906 / doi: 10.1007/s10227-005-8080-3

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004. J Cutan Med Surg 2004 Sep-Oct; 8(5): 321-37. PMID: 15868311

Sterry W, Barker J, Boehncke WH, Bos JD, Chimenti S, Christophers E, De La Brassinne M, Ferrandiz C, Griffths C, Katsambas A, Kragballe K, Lynde C, Menter A, Ortonne JP, Papp K, Prinz J, Rzany B, Rommevig J, Saurat JH, Stahle M, Stengel FM, Van De Kerkhaf P, Voorhees J. Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol 2004 Aug; 151 (s69): 3-17. PMID: 15265063

Langley R, Gupta AK, Poulin Y, Guenther L, Barber K, Gulliver W, Lynde C. The use of alefacept in the treatment of psoriasis. J Cutan Med Surg 2004 Aug; 8(S1): 14-8. PMID: 1565585

Lui H, Langley R, Poulin Y, Gupta AK, Carey W, Guenther L, Searles G, Toole J, Lynde C, Gulliver W, Barber K. Incorporating biologics into the treatment of psoriasis. J Cutan Med Surg 2004 Aug; 8(S1): 8-13. PMID: 1565584

Lynde CW. Hormonal approach to the treatment of acne a Canadian perspective. J Cutan Med Surg 2004 Dec; 8(S4):1-2. PMID: 15778824

Gupta AK, Cooper EA, Lynde CW. The efficacy and safety of terbinafine in children. Dermatol Clin 2003 Jul; 21(3): 511-20. PMID: 12956204

Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, Eichenfield LF, Ferrandiz C, Giannetti A, Hanifin J, Koo JY, Leung D, Lynde C, Ring J, Ruiz-Maldonado R, Saurat JH; ICCAD II Faculty. International consensus conference on atopic dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003 May; 148 (s63): 3-10. PMID: 12694268 / doi: 10.1046/j.1365-2133.148.s63.1.x

Gupta AK, Lynde CW, Kunynetz RA, Amin S, Choi K, Goldstein E. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face. J Cutan Med Surg 2003 Feb; 7(1): 31-7. Epub 2002 Oct 9. PMID: 12362264

Endzweig-Gribetz CH, Brady C, Lynde C, Sibbald D, Lehwohl M. Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies. J Cutan Med Surg 2002 May-Jun; 6 (3 Suppl): 12-6. Epub 2002 Apr 30. PMID: 11976987

Lynde CW. Moisturizers: what they are and how they work. Skin Therapy Lett 2001 Dec; 6(13): 3-5. PMID: 11813097

Papp K, Bissonnette R, Krueger JG, Carey W, Gratton D, Gulliver WP, Lui H, Lynde CW, Magee A, Minier D, Ouellet JP, Patel P, Shapiro J, Shear NH, Kramer S. The treatment of moderate to severe psoriasis with a new anti-CD11 a monoclonal antibody. J Am Acad Dermatol 2001 Nov; 45(5): 665-74. doi: 10.1067/mjd.2001.117850

Lee J, Lynde C. Pyogenic granuloma: pyogenic again? Association between pyogenic granuloma and bartonella. J Cutan Med Surg 2001 Nov; 5(6): 467-70. PMID: 11907853

Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, Aboobaker J, Summerbell RC. Therapeutic options for the treatment of tinea capitis caused by trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 2001 Sep-Oct; 18(5): 433-8. PMID: 11737692 / doi: 10.1046/j.1525-1470.2001.01978.x

Lynde C. Nail disorders that mimic onychomycosis: what to consider. Cutis 2001 Aug; 68(2 Suppl): 9-12. PMID: 11665727

Gupta AK, Gregurek-Novak T, Konnikov N, Lynde CW, Hofstader S, Summerbell RC. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. J Cutan Med Surg 2001 Jun; 5(3): 206-10. Epub 2001 May 2. PMID: 11685666

Gupta AK, Lynde CW, Konnikov N. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol 2001 Mar; 44(3): 485-91. PMID: 11209119 / doi: 10.1067/mjd.2001.110644

Gupta AK, Konnikov N, Lynde CW. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. J Am Acad Dermatol 2001 Mar; 44(3): 479-84. PMID: 11209118 / doi: 10.1067/mjd.2001.110874

Gupta AK, Jain HC, Lynde CW, Macdonald P, Cooper EA, Summerbell RC. Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 2000 Aug; 43(2): 244-8. PMID: 10906646 / doi: 10.1067/mjd.2000.104794

Gupta AK, Dlova N, Taborda P, Morar N, Taborda V, Lynde CW, Konnikov N, Borges M, Raboobee N, Summerbell RC, Adam P, Hofstader SL, Aboobaker J. Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study. Br J Dermatol 2000 May; 142(5): 965-8. PMID: 10809856 / doi: 10.1046/j.1365-2133.2000.03479.x

Gupta AK, Konnikov N, Lynde CW, Summerbell RC, Albreski D, Baran R, Doncker PD, Degreef H. Onychomycosis: predisposed populations and some predictors of suboptimal response to oral antifungal agents. Eur J Dermatol 1999 Dec; 9(8): 633-8. PMID: 10586132

Gupta AK, Adam P, Hofstader SL, Lynde CW, Taborda P, Taborda V, Morar N, Dlova N, Raboobee N, Konnikov N, Aboobaker J, Summerbell RC. Intermittent short duration therapy with fluconazole is effective for tinea capitis. Br J Dematol 1999 Aug; 141(2): 304-6. PMID: 10468805 / doi: 10.1046/j.1365-2133.1999.02981.x

Gupta AK, Lynde CW, Konnikov N. Sequential therapy with itraconazole and terbinafine for the management of dermatophyte toenail onychomycosis. J Eur Acad Dermatol Venereol 1998; 11(S2):S2229-230.

Gupta AK, Lynde CW, Lauzon GJ, Mehlmauer, Braddock SW, Miller CA, Del Rosso JQ, Shear NH. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. Br J Dermatol 1998 Mar; 138(3): 529-32. PMID: 9580815 / doi: 10.1046/j.1365-2133.1998.02140.x

Gupta AK, Del Rosso JQ, Lynde CW, Brown GH, Shear NH. Hepatitis associated with

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login